September 9, 2014 | BATM Advanced Communications will invest up to $450,000 in Opticul Diagnostics, an Israeli company producing vitro diagnostic devices. Opticul has developed a process for the rapid diagnosis of micro-organisms based on their outer morphology using photonic laser technology. This process allows faster, cheaper and more reliable diagnostics compared to current methods. As part of the investment, BATM and Opticul will conduct joint R&D in the US and Israel to develop and launch the next prototype of the Optidet device. BATM is the provider of advanced technology for the networked telecommunications and medical lab equipment markets. Opticul is headed by CEO Prof. Israel Gannot and has already obtained FDA and European ISO approval for its early Opidet prototype.
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors

Ashdod Port Investing In Startups As Part Of Innovation Strategy

Facebook comments